HomeCompareSIMTF vs MRK

SIMTF vs MRK: Dividend Comparison 2026

SIMTF yields 1.73% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $35.5K in total portfolio value
10 years
SIMTF
SIMTF
● Live price
1.73%
Share price
$0.04
Annual div
$0.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.2K
Annual income
$192.96
Full SIMTF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — SIMTF vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSIMTFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SIMTF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SIMTF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SIMTF
Annual income on $10K today (after 15% tax)
$146.68/yr
After 10yr DRIP, annual income (after tax)
$164.02/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,432.70/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SIMTF + MRK for your $10,000?

SIMTF: 50%MRK: 50%
100% MRK50/50100% SIMTF
Portfolio after 10yr
$40.0K
Annual income
$5,153.37/yr
Blended yield
12.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

SIMTF
No analyst data
Altman Z
1.4
Piotroski
1/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SIMTF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSIMTFMRK
Forward yield1.73%2.81%
Annual dividend / share$0.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$22.2K$57.7K
Annual income after 10y$192.96$10,113.78
Total dividends collected$1.8K$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SIMTF vs MRK ($10,000, DRIP)

YearSIMTF PortfolioSIMTF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,873$172.57$11,213$373.04$340.00MRK
2$11,809$175.35$12,667$512.06$858.00MRK
3$12,814$177.99$14,439$708.14$1.6KMRK
4$13,891$180.50$16,640$988.16$2.7KMRK
5$15,046$182.88$19,432$1,394.07$4.4KMRK
6$16,285$185.13$23,057$1,992.90$6.8KMRK
7$17,612$187.26$27,889$2,894.79$10.3KMRK
8$19,034$189.27$34,518$4,286.29$15.5KMRK
9$20,558$191.17$43,912$6,494.35$23.4KMRK
10$22,190$192.96$57,714$10,113.78$35.5KMRK

SIMTF vs MRK: Complete Analysis 2026

SIMTFStock

SIM Technology Group Limited, an investment holding company, primarily designs, develops, manufactures, and sells handsets and Internet of Things (IOT) terminals in the People's Republic of China, Europe, the United States, and other Asian countries. It operates through Handsets and IOT Terminals Business, Electronics Manufacturing Services Business, and Property Management segments. The company also offers electronic manufacturing services, as well as logistics, procurement agency, administrative, and finance leasing services. In addition, it engages in the sale of goods to vending machine customers; building design and construction of smart homes; trading of snacks; development of automated test equipment; and holding of land use rights. Further, the company develops, rents, and manages properties. SIM Technology Group Limited was founded in 1986 and is headquartered in Shanghai, the People's Republic of China.

Full SIMTF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this SIMTF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SIMTF vs SCHDSIMTF vs JEPISIMTF vs OSIMTF vs KOSIMTF vs MAINSIMTF vs JNJSIMTF vs ABBVSIMTF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.